Trials / Completed
CompletedNCT07105371
Patients With ALS and Other Motor Disorders Will be Treated With Mesenchymal Cell Exosome Solution
Patients With ALS and Other Motor Discorders Will be Treated With Mesenchymal Cell Exosome Solution
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- The Foundation for Orthopaedics and Regenerative Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Patients with ALS and other Motor Discorders will be treated with mesenchymal cell exosome solution.
Detailed description
Single Arm non-controlled study. Patients are prospectively evaluated then treated. Outcomes are tracked after treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | AlloEx exosomes | This is an intranasal treatment of exosomes derived from mesenchymal stem cells. |
Timeline
- Start date
- 2024-07-14
- Primary completion
- 2025-03-14
- Completion
- 2025-03-14
- First posted
- 2025-08-05
- Last updated
- 2025-08-22
Locations
1 site across 1 country: Antigua and Barbuda
Source: ClinicalTrials.gov record NCT07105371. Inclusion in this directory is not an endorsement.